Target
Cystathionine gamma-lyase
Ligand
BDBM330331
Substrate
n/a
Meas. Tech.
In Vitro Assay
IC50
<10000±n/a nM
Citation
 Durón, SGChapman, JSydserff, SGRao, SGStein, GWade, W Cystathionine-γ-lyase (CSE) inhibitors US Patent  US9725426 Publication Date 8/8/2017 
Target
Name:
Cystathionine gamma-lyase
Synonyms:
CGL_HUMAN | CTH | Cystathionine gamma-lyase (CSE) | Cysteine-protein sulfhydrase | Gamma-cystathionase
Type:
Protein
Mol. Mass.:
44509.52
Organism:
Homo sapiens (Human)
Description:
P32929
Residue:
405
Sequence:
MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS
  
Inhibitor
Name:
BDBM330331
Synonyms:
US9725426, 2-hydrazinylacetic acid
Type:
Small organic molecule
Emp. Form.:
C2H6N2O2
Mol. Mass.:
90.0812
SMILES:
NNCC(O)=O
Structure:
Search PDB for entries with ligand similarity: